The structure of apo protein-tyrosine phosphatase 1B C215S mutant: More than just an S → O change

le Scapin, Giovanna, Patel, Sangita, Patel, Vira, Kennedy, Brian, Asante-Appiah, Ernest
Foilsithe 2001

Determinants of use of supervised delivery care under Ghana’s fee exemption policy for maternal healthcare: the case of the Central Region

le Asante-Sarpong, Henrietta, Owusu, Adobea Yaa, Saravanan, Sheela, Appiah, Ernest, Abu, Mumuni
Foilsithe in BMC Pregnancy Childbirth (2016)

Pregnancy in non-palliated functionally single ventricle: challenges of management in resource-poor settings

le Delsol-Gyan, Desrie, Aniteye, Ernest, Oppong, Samuel, Ofosu-Appiah, Ernest, Edwin, Frank
Foilsithe in Pan Afr Med J (2020)

The changing epidemiology of esophageal cancer in sub-Saharan Africa – the case of Ghana

le Tettey, Mark, Edwin, Frank, Aniteye, Ernest, Sereboe, Lawrence, Tamatey, Martin, Ofosu-Appiah, Ernest, Adzamli, Innocent
Foilsithe 2012

Colon bypass with a colon-flap augmentation pharyngoesophagoplasty

le Tettey, Mark, Edwin, Frank, Aniteye, Ernest, Tamatey, Martin, Entsua-Mensah, Ekow, Offosu-Appiah, Ernest, Adzamli, Innocent
Foilsithe in Pan Afr Med J (2015)

Unraveling the structural basis of grazoprevir potency against clinically relevant substitutions in hepatitis C virus NS3/4A protease from genotype 1a

le Guo, Zhuyan, Black, Stuart, Hu, Yuan, McMonagle, Patricia, Ingravallo, Paul, Chase, Robert, Curry, Stephanie, Asante-Appiah, Ernest
Foilsithe in J Biol Chem (2017)

Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons

le Asante-Appiah, Ernest, Curry, Stephanie, McMonagle, Patricia, Ingravallo, Paul, Chase, Robert, Nickle, David, Qiu, Ping, Howe, Anita, Lahser, Frederick C.
Foilsithe in Antimicrob Agents Chemother (2017)

Interplay of Amino Acid Residues at Positions 28 and 31 in NS5A Defines Resistance Pathways in Hepatitis C Virus Genotype 2

le Asante-Appiah, Ernest, Ingravallo, Paul, McMonagle, Patricia, Bystol, Karin, Xia, Ellen, Curry, Stephanie, Qiu, Ping, Black, Stuart, Chase, Robert, Liu, Rong, Lahser, Fred
Foilsithe in Antimicrob Agents Chemother (2019)

Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development

le Martin, Elizabeth Anne, Lai, Ming-Tain, Ngo, Winnie, Feng, Meizhen, Graham, Donald, Hazuda, Daria J., Kumar, Sushma, Hwang, Carey, Sklar, Peter, Asante-Appiah, Ernest
Foilsithe in J Acquir Immune Defic Syndr (2020)

Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors

le McGivern, David R., Masaki, Takahiro, Williford, Sara, Ingravallo, Paul, Feng, Zongdi, Lahser, Frederick, Asante-Appiah, Ernest, Neddermann, Petra, Francesco, Raffaele De, Howe, Anita Y., Lemon, Stanley M.
Foilsithe 2014

The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV G...

le Lahser, Frederick C., Bystol, Karin, Curry, Stephanie, McMonagle, Patricia, Xia, Ellen, Ingravallo, Paul, Chase, Robert, Liu, Rong, Black, Todd, Hazuda, Daria, Howe, Anita Y. M., Asante-Appiah, Ernest
Foilsithe in Antimicrob Agents Chemother (2016)

Evolutionary pathways to NS5A inhibitor resistance in genotype 1 hepatitis C virus

le Zhou, Shuntai, Williford, Sara E., McGivern, David R., Burch, Christina L., Hu, Fengyu, Benzine, Tiffany, Ingravallo, Paul, Asante-Appiah, Ernest, Howe, Anita Y.M., Swanstrom, Ronald, Lemon, Stanley M.
Foilsithe in Antiviral Res (2018)

In Vitro Antiviral Profile of Ruzasvir, a Potent and Pangenotype Inhibitor of Hepatitis C Virus NS5A

le Asante-Appiah, Ernest, Liu, Rong, Curry, Stephanie, McMonagle, Patricia, Agrawal, Sony, Carr, Donna, Rokosz, Laura, Lahser, Frederick, Bystol, Karin, Chase, Robert, Black, Stuart, Ferrari, Eric, Ingravallo, Paul, Tong, Ling, Yu, Wensheng, Kozlowski, Joseph
Foilsithe in Antimicrob Agents Chemother (2018)

In Vitro Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor

le Lai, Ming-Tain, Feng, Meizhen, Falgueyret, Jean-Pierre, Tawa, Paul, Witmer, Marc, DiStefano, Daniel, Li, Yuan, Burch, Jason, Sachs, Nancy, Lu, Meiqing, Cauchon, Elizabeth, Campeau, Louis-Charles, Grobler, Jay, Yan, Youwei, Ducharme, Yves, Côté, Bernard, Asante-Appiah, Ernest, Hazuda, Daria J., Miller, Michael D.
Foilsithe 2014

Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers

le Wang, I-Ming, Zhang, Bin, Yang, Xia, Zhu, Jun, Stepaniants, Serguei, Zhang, Chunsheng, Meng, Qingying, Peters, Mette, He, Yudong, Ni, Chester, Slipetz, Deborah, Crackower, Michael A, Houshyar, Hani, Tan, Christopher M, Asante-Appiah, Ernest, O'Neill, Gary, Jane Luo, Mingjuan, Thieringer, Rolf, Yuan, Jeffrey, Chiu, Chi-Sung, Yee Lum, Pek, Lamb, John, Boie, Yves, Wilkinson, Hilary A, Schadt, Eric E, Dai, Hongyue, Roberts, Christopher
Foilsithe 2012

Efficacy and safety of elbasvir/grazoprevir in treatment‐naive Chinese adults with hepatitis C virus infection: A randomized trial

le Wei, Lai, Jia, Ji Dong, Duan, Zhong Ping, Wang, Fu Sheng, Niu, Jun Qi, Xie, Wen, Huang, Wen Xiang, Zhang, Ming Xiang, Huang, Yan, Wang, Mao Rong, Wu, Shan Ming, Zhao, Ying Ren, Jia, Zhan Sheng, Zhao, Xu Min, Mu, Sheng Mei, Liang, Li Wen, Wang, Zaiqi, Puenpatom, Amy, Hwang, Peggy, Robertson, Michael N., Ingravallo, Paul, Asante‐Appiah, Ernest, Wei, Bo, Evans, Barbara, Hanna, George J., Talwani, Rohit
Foilsithe in JGH Open (2020)